Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats
Section snippets
Acknowledgements
This study was supported by NIDA-IRP, DHHS. BLF has received the support of the CIHR-TUSP training program.
References (47)
- et al.
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study
Lancet
(2007) - et al.
Cue dependency of nicotine self-administration and smoking
Pharmacol. Biochem. Behav.
(2001) - et al.
Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus
Pharmacol. Biochem. Behav.
(1994) - et al.
GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings
Drug Alcohol Depend.
(2002) - et al.
Pharmacologic characterization of nicotine-induced conditioned place preference
Pharmacol. Biochem. Behav.
(1985) - et al.
Baclofen attenuates conditioned locomotion to cues associated with cocaine administration and stabilizes extracellular glutamate levels in rat nucleus accumbens
Neuroscience
(2003) - et al.
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Eur. J. Pharmacol.
(1986) Drugs of abuse: anatomy, pharmacology and function of reward pathways
Trends Pharmacol. Sci.
(1992)- et al.
GABA(B) receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats
Life Sci.
(2001) - et al.
Baclofen attenuates the reinforcing effects of cocaine in rats
Neuropsychopharmacology
(1996)
Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study
Life Sci.
(2000)
The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion
Neuropharmacology
(2002)
Systemic administration of 1R,4S-4-amino-cyclopent-2-ene-carboxylic acid, a reversible inhibitor of GABA transaminase, blocks expression of conditioned place preference to cocaine and nicotine in rats
Synapse
(2002)
A potential role for GABA(B) agonists in the treatment of psychostimulant addiction
Alcohol Alcohol.
(2002)
Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules
Psychopharmacology (Berl.)
(2000)
Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats
Psychopharmacology (Berl.)
(1999)
SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
Behav. Pharmacol.
(2002)
Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking
Nicotine Tob. Res.
(2001)
Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats
Psychopharmacology (Berl.)
(2003)
A pharmacologic strategy for the treatment of nicotine addiction
Synapse
(1999)
The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats
Neuropsychopharmacology
(2003)
Severe persistent visual field constriction associated with vigabatrin
BMJ
(1997)
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat
Synapse
(2003)
Cited by (0)
Copyright © 2008 Published by Elsevier Ireland Ltd.